Super Religare Labs (SRL) Tuesday announced it had successfully completed talks for the acquisition of Piramal Diagnostics. The deal will see Super Religare takeover Piramal Diagnostics’ 107 labs, with the company’s current annual revenues generation pegged at more than Rs 200 crore. The new acquisition investment comes in the wake of Piramal Healthcare’s sell of


Home
About Us
Contact Us




